» Articles » PMID: 37406853

Late Diagnosis in the Era of Universal Newborn Screening Negatively Affects Short- and Long-Term Growth and Health Outcomes in Infants with Cystic Fibrosis

Overview
Journal J Pediatr
Specialty Pediatrics
Date 2023 Jul 5
PMID 37406853
Authors
Affiliations
Soon will be listed here.
Abstract

Newborn screening for cystic fibrosis was fully implemented in the US by 2010, but delays in timeliness of evaluation for infants with positive newborn screening tests persist. Through evaluation of national patient registry data, we determined that late initiation of cystic fibrosis care is associated with poorer long-term nutritional outcomes.

Citing Articles

Pregnancy in People With Cystic Fibrosis Treated With Highly Effective Modulator Therapy.

Goralski J, Talati A, Hardisty E, Vora N Obstet Gynecol. 2024; 145(1):47-54.

PMID: 39666984 PMC: 11630662. DOI: 10.1097/AOG.0000000000005732.


Cystic fibrosis.

Mall M, Burgel P, Castellani C, Davies J, Salathe M, Taylor-Cousar J Nat Rev Dis Primers. 2024; 10(1):53.

PMID: 39117676 DOI: 10.1038/s41572-024-00538-6.


Cystic fibrosis year in review 2023.

Swetland D, Savant A Pediatr Pulmonol. 2024; 59(12):3106-3116.

PMID: 39056532 PMC: 11601032. DOI: 10.1002/ppul.27190.


Racial inequities and rare variants: Impact on cystic fibrosis diagnosis and treatment.

Wu M, Davis J, Zhao C, Daley T, Oliver K J Clin Transl Endocrinol. 2024; 36:100344.

PMID: 38765466 PMC: 11099334. DOI: 10.1016/j.jcte.2024.100344.